By Melissa Lipman ( October 16, 2014, 3:31 PM EDT) -- Sixteen months after the U.S. Supreme Court ruled that so-called pay-for-delay deals could be challenged under federal antitrust law, a Massachusetts district court is set to become the first to apply the rule of reason to one of the pharmaceutical patent settlements in a class action over heartburn drug Nexium....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.